Fresenius Medical Care confirms 2019 targets


© Reuters. Fresenius Medical Care confirms 2019 targets

(Reuters) – German dialysis specialist Fresenius Medical Care (DE:) reported on Tuesday a 3% rise in its second-quarter revenue, citing healthy growth in its U.S. dialysis business.

The company confirmed its full-year guidance and still expects sales to rise by 3% to 7%, and adjusted net income change to be in the range of -2% to 2%, after second-quarter revenue came in broadly in line with analysts’ expectations in a Refinitiv poll.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

READ  Daimler, BMW autonomous alliance seeks to define self-driving rules

LEAVE A REPLY

Please enter your comment!
Please enter your name here